This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Patient |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ResearchSubject.
Generated Narrative: ResearchSubject
Resource ResearchSubject "example-crossover-placebo-to-drug"
identifier: id: ecsr45
status: active
progress
type: Enrollment status (ResearchSubjectStateType#Enrollment)
progress
type: Enrollment status (ResearchSubjectStateType#Enrollment)
subjectState: On-study (ResearchSubjectState#on-study)
reason: Informed consent signed ([not stated]#informedConsentSigned)
startDate: 2022-06-10
period: 2022-06-10 --> (ongoing)
study: example-ctgov-study-record
subject: cfsb1676546565857
assignedComparisonGroup: placebo
actualComparisonGroup: ap303
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.